ISSN: 2155-9880
Amir momenizadeh, asghar mohamadi
Myocardial infarction is the most important cause of morbidity and mortality in developing country.the two therapeutic strategy for treating myocardial infarction are thrombolytic therapy and primary Percutaneous coronary intervention (PCI) [1]. Some studies demonstrated that primary PCI had significant clinical benefit compared to thrombolytic therapy [2]but owing to primary PCI is not available in some hospitals some patients inevitably are treated by thrombolytic therapy and sometimes thrombolytic therapy failed to provide complete re occlusion and TIMI grade 3 is not achieved and the patients must refer to performed rescue PCI[3].